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Available online 14 May 2016Previous MRI studies conﬁrmed abnormalities in the limbic-cortical-striatal-pallidal-thalamic (LCSPT) network
or limbic-cortico-striatal-thalamic-cortical (LCSTC) circuits in patients with major depressive disorder (MDD),
but few studies have investigated the subcortical structural abnormalities. Therefore, we sought to determine
whether focal subcortical grey matter (GM) changes might be present in MDD at an early stage. We recruited
30 ﬁrst episode, untreated patients with major depressive disorder (MDD) and 26 healthy control subjects.
Voxel-based morphometry was used to evaluate cortical grey matter changes, and automated volumetric and
shape analyses were used to assess volume and shape changes of the subcortical GM structures, respectively.
In addition, probabilistic tractography methods were used to demonstrate the relationship between the subcor-
tical and the cortical GM. Compared to healthy controls, MDD patients had signiﬁcant volume reductions in the
bilateral putamen and left thalamus (FWE-corrected, p b 0.05). Meanwhile, the vertex-based shape analysis
showed regionally contracted areas on the dorsolateral and ventromedial aspects of the bilateral putamen, and
on the dorsal and ventral aspects of left thalamus inMDDpatients (FWE-corrected, p b 0.05). Additionally, a neg-
ative correlation was found between local atrophy in the dorsal aspects of the left thalamus and clinical variables
representing severity. Furthermore, probabilistic tractography demonstrated that the area of shape deformation
of the bilateral putamen and left thalamus have connections with the frontal and temporal lobes, which were
found to be related to major depression. Our results suggested that structural abnormalities in the putamen
and thalamus might be present in the early stages of MDD, which support the role of subcortical structure in
the pathophysiology of MDD. Meanwhile, the present study showed that these subcortical structural abnormal-
ities might be the potential trait markers of MDD.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Volumetric analysis
Shape analysis
Putamen
Thalamus1. Introduction
Major depressive disorder (MDD) is a highly prevalent complex
neuropsychiatric condition characterised by a broad range of symp-
toms, with a yearly increase in morbidity and a high risk of mortality
(Raes et al., 2006; Sullivan et al., 2000). Approximately 50–75% of
MDD patients experience more than one clinically signiﬁcant episode
in their lifetimes (Association, A.P., 2000), and subsequent episodes re-
duce the effectiveness of antidepressant medication (Angst, 1999).
Early studies suggested that psychological treatments earlier in life
and at earlier stages of illness reduced the rate of recurrence of depres-
sive episodes (Kaymaz et al., 2008). Therefore, understanding the path-
ophysiology ofMDDat the timeof theﬁrst episodemayprovide insights
into prevention and early treatment for this debilitating illness.ing, The First AfﬁliatedHospital,
ing 650032, Yunnan, China.
. This is an open access article underWhereas the pathophysiology of MDD remains unknown, computa-
tional analyses of brain structural MRIs, especially voxel-based mor-
phometry (VBM) and volumetric analyses, are beneﬁcial for
understanding the relationship between structural changes and patho-
logic processes in MDD. In previous VBM reports, volume reductions in
the frontal regions, especially the anterior cingulated cortex,
orbitofrontal and prefrontal cortices, and the hippocampus, have the
most consistent results in MDD patients (Bora et al., 2012; Lai, 2013;
Serra-Blasco et al., 2013; Zou et al., 2010). Especially, the hippocampal
volume reductions were considered to be an early potential marker in
ﬁrst-episodepatientswithMDD(Frodl et al., 2002b). Besides, larger vol-
umes of amygdala were also found in ﬁrst-episode patients with MDD
(Frodl et al., 2002a; Frodl et al., 2003), and correlated positively with
the severity of depressive state (van Eijndhoven et al., 2009). These in-
vestigations indicated that the anatomical structure changes are in ac-
cordance with the hypothesis of abnormality in the cortic-limbic
circuit (Malykhin et al., 2012; Mayberg, 1997), which may contribute
to the pathophysiology of MDD. Although the hippocampus, a part ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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MDDpatients, several studies recently demonstrated that the functional
and structural abnormalities of other subcortical GM associatedwith af-
fective processing, especially the striatum (Heller et al., 2009) and thal-
amus (Webb et al., 2014), may also be associated with MDD. For
example, the caudate nucleus is one of the central loci for reward-
based behavioural learning, and therefore is intricately involved in plea-
sure andmotivation (Haruno et al., 2004). Therewere also a few studies
demonstrating that MDD may be associated with a neuropathological
process affecting neurocircuitry involving the connections between
the frontal cortex, striatum, thalamus and the related parts of the limbic
systemwithin the limbic-cortico-striatal -thalamic-cortical (LCSTC) cir-
cuits (Yeh et al., 2010) or the limbic-cortical-striatal-pallidal-thalamic
(LCSPT) network (Drevets et al., 2008; Sheline, 2000), suggesting the in-
volvement of some subcortical structures in the pathology of MDD.
However, only the structural abnormality of the hippocampus was
found in most VBM studies, and the structural abnormalities of other
subcortical nuclei, especially the striatum and thalamus, were not well
studied.
Recently, many studies demonstrated that traditional VBM analyses
of structuralMRIswere not sensitive to subtle changes in the subcortical
GM (Menke et al., 2014; Nemmi et al., 2015). A few studies began to use
the vertex-based shape analysis for exploring themorphological chang-
es of the subcortical GM in Parkinson and Alzheimer's disease (Menke
et al., 2014; Štepán-Buksakowska et al., 2014), providing useful infor-
mation about the location and pattern of morphological changes of
the subcortical GM. Because shape analysis can precisely localise region-
al shape deformations in the subcortical GM and detect changes that are
not found in VBM and volumetric analyses, they are now increasingly
used to study subcortical GM in a variety of neurological and psychiatric
disorders. In this context, shape analyses could provide a sensitive,
quantitative biomarker for focal subcortical GM atrophy.
This present study aims to determine whether focal subcortical GM
changes are present at the early stage of MDD or not and to elucidate
their relationshipswith clinical severities. Tominimise confounding fac-
tors that are known to possibly affect GM changes, we only recruited
untreated, ﬁrst episode MDD patients. Speciﬁcally, voxel-based mor-
phometry (VBM), automated volumetric and vertex-based shape analy-
ses will be used to assess focal, subtle changes of the subcortical GM. In
addition, probabilistic tractography will be used to demonstrate the re-
lationships between subcortical and cortical GM.
2. Materials and methods
2.1. Subjects
Thiswas a retrospective study and the ethics committee of Kunming
Medical University approved the study protocol. In this study, 35 ﬁrst
episode and drug-naive patients were recruited from the psychiatry de-
partment of the First Afﬁliated Hospital of KunmingMedical University,
but ﬁve of the 35 patients were excluded due to obvious structural ab-
normalities detected by T2-weighted MRI. Ultimately, 30 ﬁrst episode
and drug-naive patients (15 women and 15 men, age range
18–52 years; 100% right handed; education years range = 12–23)
were recruited. Two experienced psychiatrists independently made
the diagnosis of MDD according to the diagnostic assessment using
the Structured Clinical Interview for DSM-IV-Patient Edition (SCID-P).
All of the MDD patients also had a score of 18 or greater (scores
range: 18–34) on the 17-item Hamilton Depression Rating Scale
(HDRS). Those patients that had other comorbid Axis I and Axis II psy-
chiatric disorders, such as schizophrenia, bipolar affective disorder,
and personality disorders, were excluded from this study according to
the SCID-I and SCID-II assessments. The MDD patients included in the
study never received anti-depressivemedications before theMRI exam-
inations. All patients involved in the study provided written informed
consent.A total of 30 healthy control subjects (HCs), matched for age, gender
and number of years of education, were also recruited from Kunming,
but four of the 30 HCs were also excluded due to obvious structural ab-
normalities detected by T2-weighted MRI. Ultimately, 26 healthy con-
trol subjects (HCs) were recruited. They were screened using a
diagnostic interview, the Structured Clinical Interview for DSM-IV
Nonpatient Edition (SCID-NP), to rule out current or past DSM-IV Axis
I disorders. They were also interviewed to afﬁrm that there was no his-
tory of psychiatric illness in their ﬁrst-degree relatives. All subjectswere
right-handed andwithout severe or acutemedical conditions physically
based on clinical evaluations andmedical records. All of thehealthy con-
trol subjects involved in the study provided written informed consent.
2.2. Magnetic resonance imaging acquisition
All participants were scanned on a Philips 3T achieva TX scanner
with an eight-channel head coil. A high-resolution 3D TFE sequence
was acquired with the following parameters: TR = 7.7 ms, TE =
3.6ms, matrix=228 × 228, FOV=250mm× 250mm, 230 axial slices,
acquisition time = 6 min 53 s. A diffusion tensor image sequence was
appliedwith the following parameters: TR=7173ms, TE=78ms,ma-
trix= 115 × 115, FOV= 230mm× 230mm, 50 axial slices, slice thick-
ness=3mm, diffusion directions=32, acquisition time=9min 7 s. In
addition, axial T2-weighted MR images were acquired with the param-
eters: TR = 2500 ms, TE = 80 ms, matrix = 332 × 225, FOV =
250 mm× 220 mm, slice thickness = 6 mm, 18 axial slices, acquisition
time = 55 s. The anatomical MR images were re-evaluated for any
structural abnormalities and were reported as normal in all subjects.
2.3. Voxel-based morphometry
T1-weighted 3D TFE data were analysed using FSL-VBM (Douaud
et al., 2007), an optimised voxel-based morphometry protocol (Good
et al., 2001) carried out using FSL tools (Smith et al., 2004). First, struc-
tural images were brain-extracted. Then, a tissue-type segmentation
was carried out. The resulting grey matter partial volume images were
then aligned to MNI152 standard space using the afﬁne registration
tool FLIRT (Jenkinson et al., 2002; Jenkinson and Smith, 2001), followed
by nonlinear registration using FNIRT. Second, the registered images
were averaged to create a study-speciﬁc template. Then, we registered
all the grey matter images to the template, and smoothed these modu-
lated segmented images using an isotropic Gaussian kernelwith a sigma
of 3 mm. Finally, the voxel-wise GLM was applied using an analysis of
covariance (ANCOVA), and the effects of age and genderwere regressed
out. The statistical threshold was set at p b 0.05, corrected for multiple
comparisons (family-wise error, FWE) using the cluster-wise approach.
In addition, the associations between GM volume changes and clinical
variables (Hamilton Depression Rating Scale (HDRS) score) were also
explored (FWE-corrected, p b 0.05).
2.4. Subcortical grey matter volumetric analysis
We segmented the bilateral hippocampus, amygdala, accumbens
nucleus, caudate nucleus, pallidum nucleus, putamen nucleus and thal-
amus, respectively, from each subject's T1 3D TFE image using FMRIB's
Integrated Registration and Segmentation Tool (FIRST), part of FMRIB's
Software Library (FSL 5.0.8, http://www.fmrib.ox.ac.uk/fsl).
For each subject, brain tissue volume, normalised for subject head
size, was estimated with SIENAX, part of FMRIB's Software Library.
SIENAX starts by extracting brain and skull images from the single
whole-head input data. The brain image is then afﬁne-registered to
the MNI152 space (using the skull image to determine the registration
scaling); this is primarily aimed at obtaining the volumetric scaling fac-
tor, to be used for normalisation of head size.
The results of each step of the image processing, most importantly
the subcortical segmentation, were carefully examined to ensure
Table 1
Clinical data of MDD patients and control subjects.
MDD patients (n= 30) HCs (n= 26) p
Age(years) 34 ± 10.75 31.42 ± 6.5 p= 0.276 N 0.05
Gender (female/male) 15/15 13/13 p= 1.00 N 0.05
Hand(left/right) 0/30 0/26
Education years 15.06 ± 3.62 16.69 ± 4.05 p= 0.119 N 0.05
HDRS scores 23.73 ± 4.8
Data are expressed as mean ± standard deviation.
Unpaired t-test for the continuous variables and Pearson chi-square test for the gender
were performed using the SPSS.
MDD= Major Depressive Disorder, HCs = Healthy Control subjects, HDRS = Hamilton
Depression Rating Scale.
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volumes of each subcortical region-of-interest were adjusted for inter-
individual head size differences via multiplication by the volumetric
scaling factor derived fromSIENAX (Smith, 2002). All statistical analyses
were carried out using IBM SPSS Statistics (version 17.0; IBM, Armonk,
New York). Statistical comparisons between MDD patients and healthy
controls were carried out separately for the left and the right sides using
an analysis of covariance (ANCOVA), adjusting for the effects of age and
gender. The signiﬁcance level was set at p b 0.05, corrected for multiple
comparisons using Bonferroni correction.
Relationships between subcortical GM volumes and clinical factors
were further explored. Speciﬁcally, correlations between GM volumes
and the Hamilton Depression Rating Scale (HDRS) score were assessed
using Pearson partial correlation analysis after controlling for the effects
of age and gender (p b 0.05). Statistical analyses were conducted using
SPSS.
2.5. Shape analysis of subcortical grey matter
A vertex analysis was performed using FIRST in a mode of operation
that aims to assess group differences on a per-vertex basis by using a
multi-variate General Linear Model. To normalise for inter-individual
head size differences, the meshes were reconstructed in the MNI
space. Group comparisons of vertices were carried out using F-
statistics. The effects of age and gender were regressed out. p b 0.05
was considered statistically signiﬁcant, corrected for multiple compari-
sons (family wise error, FWE) using the cluster-wise approach. The as-
sociations between regional shape changes of the subcortical GM and
clinical variables (HDRS scores) were also explored (FWE-corrected,
p b 0.05).
2.6. Probabilistic tractography
For each subject, we used all clusters that had a signiﬁcant shape dif-
ference between two groups or correlations between the shape defor-
mation and HDRS scores in MDD patients. These were seed masks for
the probabilistic tractography. We linearly registered the individual
fractional anisotropy maps to the relative T1 images using FLIRT
(Jenkinson et al., 2002; Jenkinson and Smith, 2001). Then, we
nonlinearly registered the T1 images to the MNI template using FNIRT.
Finally, the afﬁne matrix and warps calculated with FNIRT were com-
bined to obtain a deformation ﬁeld mapping of the B0map of each sub-
ject to the MNI space. This ﬁnal shape deformation ﬁeld, which was
calculated in theMNI space, was used to register the clusters of local at-
rophy to the diffusion space of each subject.
Probabilistic tractographywas performed for every voxel in the cho-
sen seed mask, generating 5000 samples from each seed voxel to build
up the connectivity distribution. In addition, we discarded all pathways
that entered any of the non-signiﬁcant voxels by using the non-
signiﬁcant voxels as an exclusion mask. For each subject and seed
mask, individual tractography maps were normalised by dividing the
number of streamlined samples present in each voxel by the ‘waytotal’,
which corresponds to the total number of streamlined samples. Then,
the mean streamlined samples were calculated voxelwise for all sub-
jects and for each cluster. These resulting maps were then thresholded
to a value equal to 1% of the maximum voxel intensity value in the
map and were binarised as the mask of these tracts(Menke et al.,
2014; Nemmi et al., 2015).
Next, we registered the binarised tracts mask to each subject's FA,
MD, and radial diffusivity (RD) maps using the previously described
transformations from the MNI 1 mm space to the diffusion space.
Then, we extracted the mean FA, MD, and RD values from the binarised
tracts mask and compared those values between the MDD and the con-
trol groups using nonparametric two independent samples t-tests. The
signiﬁcance level was set at p b 0.05 (one-tailed and
uncorrected)(Menke et al., 2014).3. Results
3.1. Demographics and clinical information
Clinical data for 30 right-handed major depressive disorder (MDD)
patients and 26 matched health controls (HCs) are presented in
Table 1. The two groups did not differ in age (p = 0.276, gender (p =
1.00), or number of years of education (p=0.119). ThemeanHamilton
Depression Rating Scale (HDRS) score for the MDD patients was
23.73 ± 4.8 (range = 18–34). Data are expressed as mean ± standard
deviation. An unpaired t-test for the continuous variables and a Pearson
chi-square test for gender were performed using the Statistical Package
for Social Sciences (SPSS) (version 17.0; IBM, Armonk, New York).
3.2. Voxel-based morphometry analysis
VBM showed no signiﬁcant regions of either reductions or increases
in cortical and subcortical GM volume in MDD patients compared to
controls at the threshold of FWE-corrected p b 0.05. In addition, there
was no region with signiﬁcant correlations of GM volume changes
with disease severity (HDRS score) in the patients.
3.3. Volumetric analysis of subcortical grey matter
The volume of each subcortical GM was obtained respectively from
each subject's T1 3D TFE image, normalised for inter-individual head
size differences via multiplication by the volumetric scaling factor de-
rived from SIENAX. Statistical comparisons between the MDD patients
and healthy controls were carried out separately for the left and the
right sides using ANCOVA, and the effects of age and gender were ad-
justed. Table 2 shows the statistical results for normalised volumes of
the 14 subcortical GM structures. Compared to controls, MDD patients
had a signiﬁcant volume reduction in the left putamen nucleus (p =
0.033, Bonferroni corrected, p = 0.046), right putamen nucleus (p =
0.025, Bonferroni corrected, p = 0.038), and the left thalamus (p =
0.024, Bonferroni corrected, p= 0.016). But there was no difference in
volumes of other subcortical GM between the MDD patients and con-
trols (see Supplementary Table 1).
Correlations between subcortical GM volumes and HDRS scores
were assessed using the Pearson partial correlation analysis after con-
trolling for the effects of age and gender. However, there were no corre-
lations between the subcortical GM volumes changes and HDRS scores
(see Supplementary Table 2).
3.4. Shape analysis of subcortical grey matter
We observed between-group comparisons of vertex-wise shapes
that showed signiﬁcant regional shape deformation on the dorsolateral
and ventromedial aspects of the bilateral putamen nucleus (left puta-
men, FWE-corrected, p = 0.036 b 0.05, x = −15, y = 5, z = −10;
right putamen, FWE-corrected, p = 0.022 b 0.05, x = 23, y = 6,
z = −10) (Fig 1a, Fig 1b), and the dorsal and ventral aspects of the
Table 2
Normalised volumes of subcortical GM (mm3).
MDD patients
(n= 30)
HCs
(n= 26)
ANCOVA p-value Bonferroni-corrected p-value
Left putamen 7792 ± 1596 8571 ± 794 0.033 0.046
Left thalamus 11,471 ± 1089 12,173 ± 849 0.024 0.016
Right putamen 7834 ± 796 8334 ± 798 0.025 0.038
Volumes (mean ± standard deviation) are given in mm3. ANCOVA= analysis of covariance; MDD=Major Depressive Disorder, HCs = Healthy Control subjects.
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z =−4) (Fig 1c) in MDD patients. The other subcortical GM failed to
show signiﬁcant regional shape changes in patients compared to con-
trols (see Supplementary Fig 1).
Meanwhile, there were signiﬁcant negative correlations of HDRS
scores with regional shape deformation on the dorsal side of the left
thalamus (FWE-corrected, p = 0.044 b 0.05, x = −9, y = −14, z =
6) (Fig 2) in MDD patients. However, the other subcortical GM failed
to have signiﬁcant correlations of HDRS scores with the vertex-wise
shape changes (see Supplementary Fig 2).Fig. 1. Vertex-wise comparison shows signiﬁcant regional shape deformation on the dorsolater
putamen) and the dorsal and ventral aspects of the left thalamus Panel c in MDD patients, com3.5. Probabilistic tractography
Themean tracts originating from themask of the bilateral putamen,
which have a signiﬁcant shape difference between the two groups, both
ran posteriorly towards the temporal lobe and anteriorly towards the
orbitofrontal gyrus (Fig 3a, Fig 3b). Meanwhile, the mean tracts origi-
nating from the left putamen also ran towards the dorsolateral prefron-
tal cortex (Fig 3a), and the mean tracts originating from the right
putamen ran towards the primary and supplementary motor cortices
(Fig 3c). These mean tracts did not have any signiﬁcant difference inal and ventromedial aspects of the bilateral putamen Panel a, left putamen; Panel b, right
pared to HCs (family wise error-corrected, p b 0.05).
Fig. 2. Vertex-wise comparison shows a signiﬁcant negative correlation of HRDS scores with regional shape deformation on the dorsal side of the left thalamus in MDD patients (FWE-
corrected, p b 0.05).
662 Y. Lu et al. / NeuroImage: Clinical 11 (2016) 658–666the mean MD, FA, RD, and AD values between MDD patients and con-
trols (see Supplementary Table 3).
The mean tracts originated from the mask of the left thalamus, and
had a signiﬁcant shape difference between the two groups. The mean
tracts ran posteriorly towards the temporal lobe and anteriorly towards
the orbitofrontal cortex (Fig 4). Meanwhile, the mean tracts originatedFig. 3. Probabilistic tractography shows themean tracts originating from the area of shape differ
the area of shape deformation. The green part is the ﬁbre bundle, which was generated from tfrom the shape deformation area in the dorsal aspects of the left thala-
mus, having a signiﬁcant negative correlation with HRDS scores (Fig
5). However, the mean tracts from the left thalamus also did not have
any signiﬁcant difference in the mean MD, FA, RD, and AD values be-
tween MDD patients and controls (see Supplementary Table 3).ence in the bilateral putamen. The yellow part is the putamen structure and the red part is
he area of shape deformation.
Fig. 4. Probabilistic tractography shows themean tracts originating from the area of shape difference in the left thalamus (Fig 4). The blue part is the thalamus structure and the red part is
the area of shape deformation. The green part is the ﬁbre bundle, which was generated from the area of shape deformation.
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In the present study, structural changes in the subcortical grey mat-
ter were investigated in a homogenous group of untreated, ﬁrst episode
MDD patients relative to well-matched health controls using multiple
methods, including voxel-based morphometry (VBM), and automated
volumetric and vertex-based shape analyses. First, we observed signiﬁ-
cant volume reduction and shape deformation of the bilateral putamen
and left thalamus in MDD patients. Second, we found that HDRS score
changes weremainly related to shape deformation in the dorsal aspects
of the left thalamus. In addition, vertex-wise analyses of shape differ-
ences proved to be more sensitive to subtle changes than was the
VBManalysis, demonstrating signiﬁcant shape differences of subcortical
GM between MDD patients and controls. Furthermore, probabilistic
tractographydemonstrated that the area of shape deformation of the bi-
lateral putamen and left thalamus had connections with the frontal and
temporal lobes, which were proven to be related to major depression.
An important ﬁnding of our study is that the bilateral putamen and
left thalamus volumeswere reduced inﬁrst episode, untreatedMDDpa-
tients compared to the controls. Ourﬁndings are consistentwith several
volumetric and advanced VBM studies in recent years, regarding vol-
ume reduction of the thalamus (Nugent et al., 2013; Webb et al.,
2014). Firstly, it may be related to the improvement of morphological
analysis method. Secondly, the thalamus is an integral part of the emo-
tional salience network, emotion modulation network and cognitive/
executive network (Yamamura et al., 2016). And the volume reduction
of thalamuswas considered to help account for the deﬁcits in top-down
regulation of negative emotions among individuals more prone to
experiencing depressive symptoms (Webb et al., 2014). So the volume
reduction of thalamus may be a potential early marker of MDD. Mean-
while, the putamen, part of striatum, has been associated with mood,Fig. 5. Probabilistic tractography shows themean tracts originating from the shape deformation
with HRDS scores. The blue part is the thalamus structure. The red part is the area of shape def
deformation.cognitive processes, motivation and regulation of movement
(Koolschijn et al., 2009). But there were just a few studies reported
the volume reductions of putamen. A postmortem study have demon-
strated putamen volumes reduced possibly in an unmedicated state of
patients with MDD, compared with nonpsychiatric subjects (Baumann
et al., 1999). And Andreescu et al. found that a later age of onset was
also positively correlated with smaller volumes of putamen
(Andreescu et al., 2008). In our studies, all patients were untreated,
and the average age of onset is about 34 years old. Besides, the volumet-
ric and shape analysis are considered to be more sensitive to subtle
structural changes (Menke et al., 2014). So all the factors mentioned
above could explain why the putamen have not been found in most
studies. For the volume reduction of the putamen and thalamus, al-
though robust pathological evidence was currently lacking, several
studies have provided some insight into possible links with depression.
For example, post-mortem studies have demonstrated increases of xan-
thine oxidase (XO) activity in the putamen and thalamus, possibly ac-
counting for increased oxidative stress, which plays a key role in the
aetiology of depression(Michel et al., 2010). Meanwhile, a recent PET
study showed a decrease of serotonin in the putamen and thalamus,
also playing an important role in the aetiology of depression (Meyer
et al., 2006). In addition, greater iron deposition (Steffens et al., 1998)
or lower extracellular dopamine (Meyer et al., 2001) of putamen nuclei,
which might be associated with the MDD, were found in MDD patients
compared to control subjects. Moreover, genetic polymorphism re-
search also demonstrated that an epigenetic interaction of COMT
Val158Met andMTHFR C677T polymorphisms may contribute to pu-
tamen volume differences between depressed and non-depressed
subjects (Pan et al., 2009). All of the abnormal changes mentioned
above may be blamed for volume reduction in the putamen and
thalamus.area in the dorsal aspects of the left thalamus, which have a signiﬁcant negative correlation
ormation; the green part is the ﬁbre bundle, which was generated from the area of shape
664 Y. Lu et al. / NeuroImage: Clinical 11 (2016) 658–666Meanwhile, the shape analysis demonstrated volume reductions in
the dorsolateral and ventromedial aspects of the bilateral putamen nu-
cleus in patients with MDD, leading to shape deformation of the puta-
men. Besides, probabilistic tractography demonstrated that the area of
shape deformation in the bilateral putamen not only had connections
with the orbitofrontal cortex (OFC) and temporal lobe, but also had con-
nections with DLPFC in the left putamen. In addition, it was also con-
nected with the primary and supplementary motor cortices in the
right putamen. As part of the striatum, the putamen was considered to
be composed of the limbic (the ventral putamen), associative (the
dorsorostral putamen) and sensorimotor (the dorsocaudal putamen)
subregions (Postuma and Dagher, 2006). According to previous studies,
the ventral striatum, temporal lobe (including hippocampus and amyg-
dala), dorsolateral prefrontal cortex (DLPFC), and orbitofrontal cortex
(OFC) play amajor role in emotional/motivational functions and reward
processing (Kumar et al., 2008; Lacerda et al., 2004; Redgrave et al.,
2010), and are involved in the fronto-striatal or fronto-limbic networks
(Keating et al., 2012; Vai et al., 2015). These regions were also found to
be associated with anhedonia and dejection (Heller et al., 2009), which
are two core symptoms of MDD.Meanwhile, the sensorimotor striatum
and the primary and supplementary motor cortices were implicated in
motor output (Bracht et al., 2012; Redgrave et al., 2010), andwere relat-
edwith psychomotor retardation (Walther et al., 2012), a key feature of
MDD. In addition, cognitive impairmentwas also found inMDDpatients
in several studies (Culpepper, 2015), and the associative striatum and
DLPFC were found to play an essential role in the integration of cogni-
tive functions and were implicated in the prefrontal cortex–basal gan-
glia circuit (Levy and Dubois, 2006). Therefore, based on these studies,
we can consider that different regions of the putamen may have con-
nections with the relative cortices and constitute a network that con-
tributes to the relative symptoms in MDD. Although no structural
changes in these cortices, and no difference in the mean FA, MD and
RD values of these tracts connecting the putamen and relative cortices,
were found in our studies, the shape deformation of the putamen, as a
key node of these circuits. They may contribute to the symptoms in
MDD and are involved in the striatum structural changes, as well as in
the connections with DLPFC, OFC and parts of the limbic system. Thus,
our ﬁndings were in accordance with the hypothesis of abnormality of
the limbic-cortico-striatal-thalamic-cortical (LCSTC) circuits (Yeh
et al., 2010) or limbic-cortico-striatal-pallidal-thalamic (LCSPT) net-
work (Drevets et al., 2008; Sheline, 2000) in major depression.
Within the left thalamus, local atrophy was also found in the dorsal
and ventral aspects. But the previous studies failed to locate atrophy in
the thalamus. Thus, the shape analysis is more sensitive to subtle struc-
tural changes than volumetric and VBM analysis. According to previous
studies, sensory, motor and cognitive processes are organised and inte-
grated in distinct nuclei of the thalamus, which have connections with
speciﬁc cortical and subcortical regions (Alexander et al., 1986;
Middleton and Strick, 2002). In addition, the thalamus was divided
into seven sub-regions, which have connectionswith the prefrontal cor-
tex, primary motor cortex, premotor cortex, occipital cortex, sensory
cortex, temporal lobe, and parietal lobe separately (Behrens et al.,
2003a; Behrens et al., 2003b). However, in our study, shape deformation
of the left thalamus only had connections with the orbitofrontal cortex
and temporal lobe, while the local atrophy area in the dorsal aspects
of the left thalamus, which had a signiﬁcantly negative correlation
with HDRS scores, were connected with the temporal lobe. According
to previous studies, the orbitofrontal cortex (OFC) played a major role
in emotional/motivational functions (Lacerda et al., 2004). The temporal
lobe, including the hippocampus and amygdala nucleus, which were
most oftenmentioned in previous studies,was also considered to be im-
plicated in the neural circuitry mediating major depressive disorder
(van Eijndhoven et al., 2009). The amygdala is involved in the produc-
tion of affective states and the hippocampus is involved in the regula-
tion of affective states (Phillips et al., 2003). Meanwhile, hippocampus
was also related to recollection memory and the memory of reward-associated rules (Campbell and MacQueen, 2004; Kaymak et al.,
2010). In our study, no temporal lobe and orbitofrontal structural
changes were found, and no difference in the mean FA, MD, and RD
values of the mean tracts, which were connected with the orbitofrontal
cortex, temporal lobe and thalamus, was found between the MDD pa-
tients and the controls. Thalamus is a complex sensory information
node constituted by many nuclei. Several studies demonstrated that
the thalamus connected the orbitofrontal cortex to negative emotion-
generating limbic structures, such as the amygdala (Price and Drevets,
2010; Timbie and Barbas, 2015), and was related with the deﬁcits in
top-down regulation of negative emotions among individuals more
prone to experiencing depressive symptoms (Webb et al., 2014).Mean-
while, structural changes of the dorsal aspects in the left thalamus also
showed a negative correlation with HDRS scores. Therefore, the shape
deformation area in the thalamusmight contribute to clinical symptoms
and depression severity in ﬁrst episode, untreatedMDDpatients.Mean-
while, we found that only the left thalamus had volume and shape
changes, and the cause of this result might be related to the dominant
hemisphere. In addition, the reconstructed putamen ﬁbre tracts were
also projected to the thalamus (Leh et al., 2007). Our ﬁndings in the
thalamus were also in accordance with the hypothesis of abnormality
of the limbic-cortico-striatal-thalamic-cortical (LCSTC) circuits or the
limbic-cortical-striatal- pallidal-thalamic (LCSPT) network.
However, in our study, we did not ﬁnd any volume alternation in
amygdala or hippocampus in ﬁrst-episodeMDDpatients. Inmost previ-
ous studies, the structural changes of hippocampus and amygdala were
the most consistent results in ﬁrst-episode MDD patients (Frodl et al.,
2002a; Frodl et al., 2002b; Frodl et al., 2003; van Eijndhoven et al.,
2009; Zou et al., 2010). One reasonmay due to the relatively short dura-
tion of our sample of MDD. The other reason might be attributable to
heterogeneity ofMDDpatients, such as differences inmedication status,
the number of episodes, age of onset and the sensitivity of volumetric
and shape analyses to subtle structural changes. In our study, the effects
of medication status were excluded. And recently, a large scale meta-
analysis reported that the smaller hippocampus and amygdala volumes
were associated with the age of onset and the number of episodes
(Schmaal et al., 2015). Age of onset ≤21 was associated with a smaller
hippocampus, and a trend towards smaller amygdala. But in our
study, all of MDD patients were ﬁrst-episode and the most of age of
onset was N21 years old. Besides, several research found that the vol-
ume deﬁcit of hippocampus correlated with the length of illness
(Colla et al., 2007; Frodl et al., 2008), and the hippocampal volume
was lower in MDD patients with long-duration compared to patients
with short-duration and HCs (Cheng et al., 2010). According to the clin-
ical data, most of MDD patients in our study are short-duration. There-
fore, we could consider that the all the factors mentioned above may
contribute to explain the inconsistencies in hippocampus and
amygdala.
Several limitations of our study should be addressed. First, due to the
relatively small sample size design, the results cannot be generalised to
the general population. In addition, the impact of clinical variables, such
as disease duration, age of onset, was also not evaluated. Future studies
with a larger sample size of ﬁrst episode, untreated MDD are necessary,
and the relationship between clinical factors and neuroimaging results
need to be clariﬁed in the further researches. The second limitation in-
volves the use of an automatic segmentation procedure. Althoughman-
ual segmentation is time consuming andmust be performed by a highly
trained researcher, it is still viewed as the gold standard. Nevertheless,
use of the automatic segmentation procedure has been extensively re-
ported in peer-reviewed articles (Lee et al., 2014; Menke et al., 2014;
Nemmi et al., 2015). Finally, in the end, although we discussed the rela-
tionship between subcortical GM structural changes and cognition, the
evaluation of cognitive function was not carried out, and consequently,
the exact relationships between structural changes of subcortical GM
and cognitive functions remain speculative and were not addressed
here.
665Y. Lu et al. / NeuroImage: Clinical 11 (2016) 658–6665. Conclusion
Structural abnormalities in the putamen and thalamusmay be pres-
ent in the early stages of MDD, and subcortical GM plays an important
role in the neural circuitry mediating MDD. Meanwhile, our study fur-
ther conﬁrmed the hypothesis of abnormality of the limbic-cortico-
striatal-thalamic-cortical (LCSTC) circuits or limbic-cortical-striatal
pallidal-thalamic (LCSPT) network in MDD patients, which may con-
tribute to the pathophysiology of MDD.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2016.04.008.
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